Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

Biogen Idec building

Biogen rises on more positive data for Alzheimer’s candidate

Early-stage trial throws lifeline to proponents of beleaguered amyloid hypothesis

- PMLiVE

Gilead files hepatitis C salvage regimen in US

Seeks FDA approval for combination of Epclusa and voxilaprevir

- PMLiVE

Dr Colin Goddard appointed chairman at Mission Therapeutics

Will take up the role at the Cambridge, UK firm in January

- PMLiVE

Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role

He recently retired from Lilly after more than 15 years with the firm

- PMLiVE

2017: Medical education that improves value and outcomes for patients

In December’s Issue of PME, two of Lucid’s senior management team – Shula Sarner and Tanya Goodyear – consider how medical education will evolve in 2017.   They discuss industry...

Lucid Group Communications Limited

How can pharma engage with NHS Vanguards?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore the opportunities for pharma to help NHS vanguards develop new models of care.

Wilmington Healthcare

- PMLiVE

Plugging the Gaps

How technology can aid strategic workforce planning in pharma.

EU flag

EU clears AbbVie’s leukaemia drug venetoclax

Becomes the first BCL-2 inhibitor to be approved by the EMA

Eli Lilly HQ

Lilly taps AstraZeneca for another anti-amyloid drug

MEDI1814 could potentially slow the progression of Alzheimer's

Vifor launches digital tools for iron deficiency awareness

Hopes to plug information gaps with new website and mobile app

Porter Novelli strengthens health and wellness team

Matthew Foster joins the London agency as a director

- PMLiVE

InterComm International under new management

Malcolm Allison and Ben Greeves take over the med comms agency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links